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ABSTRACT
Objective: The purpose of this study was to determine the epidemiology of sexually transmitted
diseases (STDs) among pregnant adolescents.
Methods: Charts of all patients (n 735) who attended the Maternal and Infant Care Clinic at
University Hospital, Newark, NJ, between July 1, 1991, and June 30, 1992, were reviewed for
STDs which included gonorrhea, chlamydia, syphilis, and human immunodeficiency virus (HIV).
At the first prenatal visit, each registrant had endocervical specimens obtained to detect gonorrhea
and chlamydia. A serum sample was obtained for syphilis screening. HIV testing was made avail-
able to all patients and testing was done on a voluntary basis. The same STD screening that was
done at the initial visit was repeated at 28 and 36 weeks.
Results: Twenty-five percent of patients tested positive for one or more STDs. The mean patient
age was 17.3 years. The mean gestational age at first visit was 19.5 weeks. The mean number of
visits was 7.3. The following STDs were identified: 4.8% of patients tested positive for gonorrhea,
20.9% tested positive for chlamydia, and 1.7% tested positive for syphilis. Twenty-one percent of
patients had a positive STD diagnosed at the initial visit. Another 4.8% of patients had an STD
diagnosed at some time after the initial visit when the initial screen was negative for STDs. An
additional 1% of patients who initially tested positive for an STD had subsequent screening which
revealed anotherSTD (different organism). Seven patients tested HIV positive. Sixty-one percent of
patients with STDs agreed to HIV testing. One patient had HIV coexistent with another STD.
Conclusions: Pregnant adolescents are at risk for multiple STDs. HIV testing should be offered.
STD screening should be repeated in the third trimester in adolescent patients.
(C) 1994 Wiley-Liss, Inc.
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he number of sexually active adolescents has
risen dramatically in the past 15 years. Studies
in 1988 show that 25% of 15-year-old girls and
75% of 19-year-old girls have had sexual inter-
course.
1,2 An estimated 1,014,680 teens became
pregnant in 1987, with 50% of these pregnancies
resulting in births. The teenage birth rate in 1989
(girls aged 15-19 years) was 49/1,000 among
whites and 97/1,000 among minorities; the teenage
birth rate in the United States is higher than in
many developing countries. 2’3
Pregnancies among adolescents, especially those
under age 15 years, are complicated by adverse
neonatal outcome.
4,s Research has shown, however,
that maternal age alone has little effect on poor
outcome when other contributing risk factors such
as inadequate maternal weight gain, poor nutrition,
and substance abuse are controlled for. The pres-
ence of a sexually transmitted disease (STD) repre-
sents an additional but correctable risk for the preg-
nant adolescent. Infections with herpes, syphillis,
gonorrhea, and chlamydia may cause disease result-
Address correspondence/reprint requests to Dr. Joseph Apuzzio, Department of Obstetrics and Gynecology, New Jersey
Medical School, 185 South Orange Avenue, E506, Newark, NJ 07103.
Received September 5, 1993
Clinical Study Accepted January 24, 1994PREGNANT ADOLESCENTS AND STDs GITTENS ET AL.
ing in preterm labor, chorioamnionitis, and sepsis
in the mother and pneumonia, conjunctivitis, con-
genital malformation, and sepsis in the neonate. 6’7
The range of perinatal morbidity associated with
human immunodeficiency virus (HIV) infection is
still being described. Depending upon the popula-
tion studied, 8-25% of sexually active adolescents
have endocervical infections with Chlamydia tra-
chomatis and 0.4-12% have endocervical infection
with Neisseria gonorrhoeae.
8-11 A 0.7% incidence
rate of syphilis among a group of 15-19-year-old
indigent pregnant girls has been reported.
12 AS OF
March 1990, 1,429 cases ofacquired immunodefi-
ciency syndrome (AIDS) in adolescents have been
reported to the Centers for Disease Control and
Prevention. There are no studies that review the
epidemiology of STDs including HIV in the ado-
lescent pregnant patient. To aid in targeting sites
for intervention, we studied the epidemiology of
STDs in an inner-city pregnant adolescent popula-
tion.
MATERIALS AND METHODS
All patients who had at least one prenatal visit to the
Maternal and Infant Care Clinic at University Hos-
pital, Newark, NJ, and delivered at one institution
between July 1, 1991, and June 30, 1992, were
included in the study. As part of routine prenatal
care, all patients were screened for N. gonorrhoeae,
C. trachomatis, and syphilis at the first visit. Two
endocervical specimens were obtained. The first
was inoculated on Thayer Martin medium, incu-
bated, and studied for the presence of N. gonor-
rhoeae; the second was processed for chlamydia de-
tection by immunoassay (Chlamydiazyme, Abbott
Laboratories, Chicago, IL). A serum sample was
obtained for Rapid Plasma Reagin (RPR). Fluo-
rescent treponemal antibody testing (FTA) was per-
formed on blood from all patients who tested RPR
positive. The above-described STD screening was
repeated at 28 and 36 weeks gestation.
All patients with suspicious genital lesions had
cultures for herpes simplex virus. At the first pre-
natal visit, patients were counseled regarding HIV.
Voluntary HIV screening by enzyme-linked im-
munosorbent assay (ELISA) (Recombigen, Cam-
bridge Biotech Corp., Worchester, MA) was per-
formed on all patients who agreed to testing. A
positive culture for gonorrhea or a positive Chlamy-
diazyme was considered diagnostic ofthe respective
disease. Patients were described as having syphilis
if the RPR and FTA were positive (patients with
history of infection and positive titers were ex-
cluded from this group). All patients who tested
HIV positive by ELISA had HIV confirmation by
Western blot analysis (Novapath, Bio-Rad Labora-
tories, Hercules, CA). Results of STD screening
and demographic information regarding the pa-
tient’s age, parity, gestational age at time of first
visit, and the number of prenatal visits were re-
corded.
Demographic data were reviewed to determine
measures of central tendency and proportions that
described the patient population. Results of STD
screening were reviewed to determine percentages
of disease in our population. Means and ranges
were used where appropriate.
RESULTS
Maternal Characteristics
A total of 735 adolescent patients enrolled in our
clinic delivered between July 1, 1991, and June
30, 1992. Our patients were predominantly black
and Hispanic females. Of the 735 enrolled pa-
tients, 188 patients (25.2%) had an STD. The
mean age for patients with STDs was 17.3 years
(range 12-20 years). The mean number of prenatal
visits was 7.3 (range 1-13 visits). The mean gesta-
tional age at the time of" the first visit was 19.5
weeks (range 6-35 weeks); 57 patients (30.3%)
presented for initial visit in the first trimester, 90
patients (47.8%) presented initially in the second
trimester, and 41 patients (21%) had their first
visit in the third trimester. Twenty-one percent of
patients had an STD diagnosed at the initial visit.
Follow-up STD screening was done according to
clinic protocol on all patients at 28 and 36 weeks.
This rescreening, performed on all patients and not
based upon the presence of symptoms or historical
information, revealed that 4.8% had an STD diag-
nosed at a follow-up visit after the initial STD
screen was negative. One percent had a second
STD diagnosed at the follow-up visit after the ini-
tial screen had already identified one STD. Three
percent of the patients had more than one STD.
STD Characteristics
Twenty-one percent of patients had chlamydia in-
fection [95% confidence interval (CI) 18.0-
24.0%], 4.8% had infection with gonorrhea (95%
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CI 3.3-6.3%), 1.7% new cases of syphilis were
identified, and 0.6% had infection with herpes sim-
plex virus. Seven patients tested HIV positive.
Sixty-one percent (116/188) of patients with a
known STD agreed to HIV testing. One patient
had HIV coexistent with another STD (syphilis).
The other 6 HIV-positive patients had no coexist-
ent STD.
DISCUSSION
Pregnant adolescents in our population are at risk
for multiple STDs, including HIV. ACOG guide-
lines recommend STD screening at the initial and
follow-up visits. While prenatal care has improved
for mothers in all age groups in recent years, teen-
agers continue to get the least adequate medical
attention. A 1978 study reported that mothers un-
der the age of 15 years are 2.5 times more likely
than mothers aged 20-24 years to be without pre-
natal care in the first trimester and nearly 4 times
more likely to receive no care or to delay care until
the third trimester.
4 Our studies confirm these
trends. Because more than half of adolescents pre-
sented for the first visit later than the first trimester
and because more than 20% of patients had an
STD, a scheduled follow-up visit 1-2 weeks after
initial presentation and emphatic encouragement
regarding compliance with follow-up visits are in
order. Repeated testing for STDs will identify those
adolescents who continue to test positive because of
noncompliance with therapy or continued exposure
to the untreated asymptomatic partner. Almost 5%
of patients had an STD diagnosed on repeat screen-
ing after the initial screen was negative.
The choice of an individual partner and whether
that partner resides in an area where the prevalence
of STDs is high both contribute to an adolescent’s
risk.
13,14 An understanding of the adolescent’s rea-
soning process, her concept of monogamy, and
knowledge of adolescent sexuality patterns, includ-
ing those of the male partner, will provide addi-
tional areas for intervention.
The attempt to control disease transmission in
pregnant adolescents is additionally impaired by the
fact that a significant number of teenagers have
never used a contraceptive method. Already preg-
nant teenagers may not understand the rationale for
the use of a barrier contraceptive during their preg-
nancy. In communities where the prevalence of
STDs including HIV is high, all pregnant adoles-
cents should be encouraged to use condoms if they
remain sexually active during their pregnancy.
The seroprevalence ofHIV in adolescents in our
community is unknown. There are no reported
studies that have reviewed the epidemiology of
STDs including HIV in pregnant inner-city ado-
lescents. We identified 7 HIV positive adolescents.
None of these patients had obvious risk factors for
HIV infection and thus may have acquired the
infection through heterosexual contact. Since not all
patients agreed to testing, the actual seroprevalence
rate among pregnant adolescents in our community
(at least 1%) is likely to be higher. The risk and
possibility for heterosexual transmission ofHIV in
this patient group cannot be minimized. While
others have suggested that the presence of an STD
is a sufficient factor upon which to base decisions
regarding HIV screening in adolescents, we noted
that only of the 7 patients who tested HIV posi-
tive had a coexistent STD. While it is true that 39%
ofour patients who had STDs did not agree to HIV
testing, the discovery of 6 HIV positive patients
among the group of patients who tested negative for
STDs makes the presence ofan STD an insufficient
risk factor upon which to base decisions regarding
HIV screening in our patient group. We recom-
mend the availability ofHIV counseling and screen-
ing to all pregnant adolescents, particularly those
who reside in communities where the seropreva-
lence of the disease is high.
While many programs have been developed to
meet the needs of pregnant women who test HIV
positive, specific programs that address the needs
of such infected adolescents are lacking. Ethical
and legal issues regarding testing and informing
partners, emotional differences in coping mecha-
nisms, and age-related differences in cognitive func-
tion make the diagnosis and treatment of HIV in-
fection different in the adolescent than in the adult.
While unified support groups specific for subsets
of the adult population such as homosexuals, hemo-
philiacs, and substance abusers exist, few such
groups are available to adolescents. The develop-
ment of multidisciplinary teams with specific atten-
tion to the emotional and social needs of HIV-
infected adolescents will hopefully assure better
perinatal outcomes.
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